Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119183) titled 'Correlation Between Gut Microbiota and Neoadjuvant Therapy Response in Breast Cancer: A Prospective Cohort Study' on Feb. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Observation group (breast cancer patients):500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310071
Disclaimer: Curated by HT Syndication....